Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
June 18, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
ClearStar Announces Appointment of Pam Dunsky as Chief Operating Officer
February 28, 2024 10:47 ET
|
ClearStar
ClearStar appoints Pam Dunsky as Chief Operating Officer (COO) to oversee Client Service and Operations.
Expanding Mice Model Market Propels Life Sciences Research, Forecasts a Surge to $2.54 Billion by 2030
January 24, 2024 11:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Mice Model Market by Service (Breeding, Cryopreservation, Genetic Testing), Type (Conditioned/Surgically Modified Mice, Genetically Engineered...
United States Humanized Mice Model Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
November 24, 2023 10:18 ET
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "United States Humanized Mice Model Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
ClearStar announces appointment of Mike Pritts as Chief Executive Officer
November 03, 2023 16:50 ET
|
ClearStar
Alpharetta, Georgia, Nov. 03, 2023 (GLOBE NEWSWIRE) -- ClearStar, Inc., a leading provider of modern, integrated, background, drug, and health screening solutions, is pleased to announce the...
Drug Testing Market Projected to Grow at 6.8% CAGR, Crossing US$ 13.3 Billion by 2032, Reports Marketresearch.biz
October 31, 2023 07:32 ET
|
MarketResearch.biz
New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The global drug testing market is poised for significant growth and is expected to be worth USD 13.3 billion by 2032, from USD 7.0 billion in 2022,...
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
October 27, 2023 11:00 ET
|
Psychemedics Corporation
Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
September 21, 2023 17:00 ET
|
Psychemedics Corporation
ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon...
Global Drug of Abuse Testing Market Analysis Report 2023: Increasing Government & Non-Government Institutions Initiatives to Combat Drug-Related Mortalities
September 08, 2023 04:03 ET
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, Drug Type, End Users/Setting Type, Region), Regulatory Status, Recent...
Immunohistochemistry Market worth $3.58 Billion by 2028 - Exclusive Report by The Insight Partners
August 29, 2023 07:48 ET
|
The Insight Partners
Pune, India, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue...